News 13

Bathymetry: A lesser known factor for storm surge

Storm surge is one of the primary threats when hurricanes make landfall, and there are a lot of factors involved in how high the surge can get. Some of those factors include wind speed, minimum ...
FierceBiotech

The future of RAS inhibitors

Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach ...
News Medical

FDA approves first RAS-targeted therapy for metastatic pancreatic cancer

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one ...
The American Journal of Managed Care

Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug

The FDA approved daraxonrasib, the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a survival benefit vs chemotherapy. The FDA approved daraxonrasib (Rasonque; Revolution ...
Medscape

FDA Approves RAS Inhibitor Daraxonrasib for Pancreatic Cancer

The FDA has approved the first RAS-targeted therapy for metastatic pancreatic cancer, offering a new treatment option for patients with previously treated disease. Daraxonrasib (Rasonque, Revolution ...
USNI

Navy Removes Head of Drone Programs After 8 Months, PAE Maritime Head Miller Now Leading PAE RAS

Unmanned Surface Vessel Division 12 (Sea Hunter) and 13 (Sea Hunter) conduct unit level training underway in San Diego Bay, California, May 1, 2025. US Navy photo The Navy’s portfolio acquisition ...
NOAA

How Removing Lost Crab Traps Is Helping Map the Chesapeake Bay

E.C. Hogg, a TRAP program participant, pulls up a derelict crab pot in February 2025. (Photo credit: John Wallace, William & Mary’s VIMS & Batten School). What if everyday work on the water could also ...
FierceBiotech

ASCO: Revolution Medicines confident in RAS leadership as rivals square up

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...
The New England Journal of Medicine

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer

Current therapies offer limited benefit for patients with previously treated metastatic pancreatic ductal adenocarcinoma (mPDAC). Aberrant activation of the RAS pathway is the key driver of PDAC, with ...
bilibili

HEC RAS Exercise 28 - Histograph and Sediment Loading

HEC RAS Exercise 28 - Histograph and Sediment Loading, 视频播放量 21、弹幕量 0、点赞数 0、投硬币枚数 0、收藏人数 0、转发人数 0, 视频作者 Sinoblereme, 作者简介 ，相关视频：HEC RAS Exercise 35 - 1D⧸2D Connection，HEC RAS Exercise 26 - 1D Sediment ...
bilibili

HEC RAS Exercise 9 - Lateral Structures and Storage Areas

HEC RAS Exercise 9 - Lateral Structures and Storage Areas, 视频播放量 25、弹幕量 0、点赞数 1、投硬币枚数 0、收藏人数 1、转发人数 0, 视频作者 Sinoblereme, 作者简介 ，相关视频：HEC RAS Exercise 41 - Raster Calculating a Safe Recreation Area，HEC ...